drugset / Trial / NCT00258180
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
NaSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Cyclophosphamide may help control the symptoms of autoimmune enteropathy . PURPOSE: This phase II trial is studying how well cyclophosphamide works in treating young patients with severe autoimmune enteropathy.
Timeline
- Start
- 2005-08-15
- Primary completion
- 2009-02-24
- Completion
- 2009-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | filgrastim | Protein / enzyme biologic | — | Intravenous |